Celularity Inc. Director Granted 30,000 Restricted Stock Units (RSUs)
Celularity Inc
Subscribe to track CELU
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Celularity Inc. Director Granted 30,000 RSUs
Company: Celularity Inc (CELU) Form: 4/A | Filed: 2026-01-15 Significance: Low
Insider: Parks Diane L. Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 30,000 RSUs • Price: $0.00 • Value: $0 • Owned After: 520,021
Key Insight: This is a routine grant of Restricted Stock Units (RSUs) to a director as part of their compensation, intended to align their interests with shareholders.
Market Context: For a company with a $40 million market cap, such equity compensation is a standard practice and is not considered a significant market signal.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Celularity Inc (CELU)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine grant of 30,000 Restricted Stock Units (RSUs) as part of their compensation package.
- Market Impact: Neutral. This is a standard corporate governance action and not a direct market signal.
Company Information
| Field | Value |
|---|---|
| Company | Celularity Inc |
| Ticker Symbol | CELU |
| CIK | 0001752828 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Parks Diane L. |
| CIK | 0001781026 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4/A |
| Transaction Date | 2026-01-12 |
| Transaction Code | A (Award) |
| Security Type | Class A Common Stock (as RSUs) |
| Shares Involved | 30,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 520,021 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 30,000 |
| % of Shares Outstanding | Data Not Available |
| Post-Transaction Ownership | 520,021 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The company has a market capitalization of approximately $40 million. The grant has a transaction value of $0, making its immediate financial impact negligible as a percentage of market cap.
- Ownership Concentration: The director now holds 520,021 shares. Without shares outstanding data, the exact ownership percentage cannot be determined.
- Dilution Impact: The issuance of 30,000 new shares upon vesting will cause minor dilution to existing shareholders. The exact percentage impact cannot be calculated without the total shares outstanding figure.
- Transaction Significance: The transaction is an equity award, a common form of non-cash compensation for directors. It is not an open-market purchase and carries low significance as a trading signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to directors are routine and expected forms of compensation. They do not signal new information about the company's immediate prospects.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open-market transaction and will not directly affect trading volume.
- Sentiment Indicator: Neutral. The market generally views such compensation as a standard cost of doing business.
Additional Context
Transaction Notes
- Special Circumstances: The filing notes these are Restricted Stock Units (RSUs) granted under the company's 2021 Equity Incentive Plan. The RSUs vested immediately upon grant.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
